Priority 1 from the Neurodevelopmental Disorders Canada PSP
UNCERTAINTY: What are the most effective treatment options/plans (e.g., timing, frequency, duration, type, intensity or dosage) for individuals with neurodevelopmental disorders for both short and long-term benefits? (JLA PSP Priority 1) | |
---|---|
Overall ranking | 1 |
JLA question ID | 0056/1 |
Explanatory note | This question is aimed at understanding the what combination of treatments are best for achieving short-term outcomes vs. long-term outcomes, but also goes beyond this by determining when to take certain treatments, at what intensity or dosage and for how long and how often. |
Evidence | None identified |
Health Research Classification System category | Mental Health |
Extra information provided by this PSP | |
---|---|
Original uncertainty examples | What are the best ages or developmental stages for treatment to begin? ~ What are the best treatments (both medication and behavioural) for these disorders? ~ What is the level of intensity required for different therapies in order to maximize effectiveness? ~ How long is the intervention supposed to be effective before it plateaus? ~ what are the most effective, least-intrusive interventions for persons with different kinds of neurodevelopmental disorders? |
Submitted by | Mostly family members/carers and clinicians, also some service providers and members of organizations |
PSP information | |
---|---|
PSP unique ID | 0056 |
PSP name | Neurodevelopmental Disorders (Canada) |
Total number of uncertainties identified by this PSP. | 63 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
Date of priority setting workshop | 28 September 2017 |